News

Thorsten Stafforst recalls being discouraged from pursuing his research. In the early 2010s, scientists were excited about CRISPR, a tool […]

At a conference in New England, Rohan Simon, an associate director at the UAE’s first contract research organization, discussed the […]

Here’s a simplified summary of the recent news from Biogen, Novartis, Resalis Therapeutics, and Moderna: Biogen: The biotech company has […]

The FDA has given special status to a new treatment called MDL-101 by Modalis Therapeutics for a rare muscle disorder […]

GSK, a pharmaceutical company, is spending $300 million to buy a special type of drug from Chimagen Biosciences, a company […]

Ultra-processed foods (UPFs) are linked to health issues like obesity, diabetes, heart disease, and some cancers. In India, obesity rates […]

Pfizer recently reported strong earnings for the third quarter, surpassing Wall Street expectations. As a result, the company has increased […]

AbbVie has agreed to buy Aliada Therapeutics for $1.4 billion. This deal includes Aliada’s main product, ALIA-1758, which is being […]

The UK government and its drug regulator have issued a warning about the misuse of certain weight-loss medications. These drugs, […]

A recent trial found that nearly 60% of patients with a rare condition called eosinophilic granulomatosis with polyangiitis (EGPA) went […]